EDGAR Filing Documents for 0001193125-17-158981

Form POS AM - Post-Effective amendments for registration statement:

SEC Accession No. 0001193125-17-158981

Filing Date

2017-05-04

Accepted

2017-05-04 17:16:05

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	POS AM	d382124dposam.htm	POS AM	561957
2	EX-10.22	d382124dex1022.htm	EX-10.22	60290
3	EX-23.1	d382124dex231.htm	EX-23.1	1701
4	GRAPHIC	g382124g37d51.jpg	GRAPHIC	30877
5	GRAPHIC	g382124g38q46.jpg	GRAPHIC	138876
	Complete submission text file	0001193125-17-158981.txt		858944

Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752

Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861

RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)